OOIR: Observatory of International Research

Papers

(The H4-Index of Open Forum Infectious Diseases is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
1012. Neutrophil Function Enhanced by Recombinant Interferon-Gamma in Newborns	195
727. Predictors of Depressive Symptoms in Pregnant Partners in Seroconcordant Couples Living with HIV in Zambézia Province, Mozambique	164
294. Surveillance for Potential Post-Acute COVID-19 Syndrome Medical Complications in the Emergency Department (ED) – A Retrospective Longitudinal Study of ED Patients Who Had Evidence of SARS-CoV-2 I	131
20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis	122
01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Yo	113
969. Gamification for Infectious Diseases Medical Education: Creating a Videogame to Teach COVID 19 Diagnosis and Treatment to Medical Students	109
1232. In Vitro Activity of Cefiderocol and Comparator Agents against Molecularly characterized Carbapenem-resistant Enterobacterales Clinical Isolates Causing Infection in United States	104
1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine	87
1339. Impact of COVID-19 Pandemic on Activity of Other Respiratory Viral Pathogen and Norovirus	86
1374. Clinical Outcomes of Sepsis According to Race at University of Minnesota Medical Center	79
1133. Opportunities for Antibiotic Discontinuation and De-escalation after Discharge from the Emergency Department in Pediatric Patients with UTI	79
59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections	77
426. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care	70
1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States	68
706. Effect of the Covid-19 Pandemic on Rates of Recurrent Clostridiodes difficile Infection in the Veterans Affairs System	68
398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States	67
1252. In Vitro Activity of Aztreonam-Avibactam and Comparator Agents Against Enterobacterales from Patients with Bloodstream Infections collected during the ATLAS Global Surveillance Program, 2	66
266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis	66
751. Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory	65
509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation	64
124. Activity of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations Against AmpC-Producing Species Collected in United States Hospitals	64
405. Utilization of a novel humble inquiry interview approach in assessing implementation barriers to a Nurse Driven Clostridioides difficile infection (CDI) order set	63
382. Are errors of omission falsely inflating hospital-onset Clostridioides difficile infection numbers?	63
606. Efficacy and Safety of Ceftazidime-Avibactam Comparative Dosage Regimens in Patients with Kidney Injury: A Retrospective Cohort Study	60
1685. Antimicrobial Activity of Aztreonam-Avibactam Against Enterobacterales Causing Infection in United States Hospitals (2019-2021)	57

1430. Eravacycline associated hypofibrinogenemia during treatment of M.abscessus	56
326. Optimizing DNA Extraction from Pediatric Stool for Diagnosing Tuberculosis and Use in Next Generation Sequencing	54
639. Vaccination in Kidney Transplant Candidates	50
1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-19	49
1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 2021	49
738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia	48
1034. Risk Score for the Need of Mechanical Ventilation in Adults Presenting with Encephalitis.	48
1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience	47
1244. Inpatient vs. outpatient initiation of Hepatitis C treatment among hospitalized patients who inject drugs: Lessons from a quality improvement project	46
1322. Infectious Complications Following Pediatric Lawn Mower Injury: A Case Series	46
1957. Increased short-term vaccine effectiveness of BNT162b2 with same-arm vs. cross-arm administration of sequential doses	45
1301. ID Fellows Cup: Developing Confidence Through Content Creation	45
1405. High risk or unstable substance use may predict OPAT nonadherence among people who use drugs (PWUD) admitted with invasive infections	45
620. Pharmacokinetic-Pharmacodynamic Analysis of Oral Vancomycin and Gut Microbiome Changes in Healthy Volunteers: an Exploratory Study	45
665. Modified Superposition in vitro Susceptibility of Aztreonam and Ceftazidime/Avibactam for an NDM-5 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolate	44
2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States	43
537. First Week Post-Operative C-Reactive Protein Kinetics Show Different Patterns of Association with Infection Depending on the Type of Surgery	43
121. Safety, Tolerability, and Pertussis Immunogenicity Findings From a Randomized, Participant-Blinded, Active-Controlled, Dose-Escalating, Phase 1 Trial of a Tetanus/Diphtheria/Pertussis Booster Vac	42
603. Comparing assays for Clinical Phage Microbiology in biofilm	42